论文信息 - Safety, pharmacokinetics and antiviral activity of ABI‐H2158, a hepatitis B virus core inhibitor: A randomized, placebo‐controlled phase 1 study - 字舞流文

Safety, pharmacokinetics and antiviral activity of ABI‐H2158, a hepatitis B virus core inhibitor: A randomized, placebo‐controlled phase 1 study

T. Hassanein | M. Yuen | D. J. Kim | K. Agarwal | E. Gane | K. Zomorodi | Yanhua Ding | L. Stamm | R. Yan | Y. Lim | S. Knox | Qi Huang | M. Evanchik | Tuan T. Nguyen | Julie Ma | R. Colonno | K. Alves | Jia Xu